MASSACHUSETTS GENERAL HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
- Conditions
- Small-cell Lung CancerNon Small Cell Lung CancerMesotheliomaCognitive Behavioral Therapy
- Interventions
- Behavioral: Run-In Sessions 1-5Behavioral: RCT Control SessionBehavioral: RCT Transitions Program Sessions 1-5
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT04450043
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Impact of Transcutaneous Vagal Nerve Stimulation on Stress Response in Major Depression
- Conditions
- Major Depressive Disorder
- Interventions
- Device: Sham tVNSDevice: active tVNS
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04448327
- Locations
- 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Financial Incentives for Homeless Smokers: A Community-based RCT
- Conditions
- Tobacco Smoking
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 184
- Registration Number
- NCT04445662
- Locations
- 🇺🇸
Boston Health Care for the Homeless Program, Boston, Massachusetts, United States
Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study
- Conditions
- Colon Cancer
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 203
- Registration Number
- NCT04432870
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
KRDI in Transplant-Eligible MM
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT04430894
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
- Conditions
- Vulvar CancerVulvar Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT04430699
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04430712
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Gamma-Induction in FrontoTemporal Dementia Trial
- Conditions
- Frontotemporal Dementia
- Interventions
- Device: Sham Transcranial Alternating Current Stimulation (sham tACS)Device: Transcranial Alternating Current Stimulation (tACS)
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT04425148
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇮🇹Fondazione Santa Lucia, Roma, Italy
Home Hospital for Lymphoma
- Conditions
- Lymphoma
- Interventions
- Other: Home Hospital for Lymphoma
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 3
- Registration Number
- NCT04423848
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Niraparib + Dostarlimab + RT in Pancreatic Cancer
- Conditions
- Pancreatic CancerMetastatic Pancreatic Cancer
- Interventions
- First Posted Date
- 2020-06-01
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT04409002
- Locations
- 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States